Pharmanutra — Proxy Solicitation & Information Statement 2026

Apr 6, 2026

teleborsa

Informazione Regolamentata n. 20106-15-2026	Data/Ora Inizio Diffusione 6 Aprile 2026 19:22:27	Euronext Star Milan

Societa': PHARMANUTRA

Utenza - referente : PHARMANUTRAN04 - Simona del Re

Tipologia : REGEM; 3.1

Data/Ora Ricezione : 6 Aprile 2026 19:22:27

Oggetto : PR | PUBLICATION OF THE LISTS SUBMITTED FOR THE APPOINTMENT OF THE BoD

Testo del comunicato

Vedi allegato

---

emarket

with storage

CERTIFIED

PHARMANUTRA

PHARMANUTRA S.P.A.

PUBLICATION OF THE LISTS SUBMITTED FOR THE APPOINTMENT OF THE BOARD OF DIRECTORS AND THE RELATED PROPOSED RESOLUTIONS

Pisa, 6 April 2026 – With reference to the Shareholders' Meeting of Pharmanutra S.p.A. ("Pharmanutra") convened for 27 April 2026 at 3:00 p.m., it is hereby announced that, as of 2 April 2026 (the deadline set for the submission of lists), two lists of candidates for the appointment of the Board of Directors, referred to under item 3 on the agenda, were submitted in accordance with the applicable laws and the Articles of Association.

List no. 1 submitted by the shareholder ALH S.r.l. (holder of an overall shareholding equal to 31,384% of the share capital):

1. Andrea Lacorte (*)
2. Roberto Lacorte
3. Carlo Volpi
4. Germano Tarantino
5. Simona Del Re
6. Alessandro Calzolari (**)
7. Elena Pro (**)
8. Marida Zaffaroni (**)
9. Giovanna Zanotti (**)

() Indicates the candidate for the office of Chairman of the Board of Directors.
(*) Candidate who has declared that he/she meets the independence requirements set forth in Article 148, paragraph 3, of Legislative Decree No. 58/1998 ("TUF") and in Article 2, Recommendation 7, of the Corporate Governance Code approved by the Corporate Governance Committee.

List no. 2 submitted by institutional investors collectively representing 3,29491% of the share capital:

Pharmanutra S.p.A.

Via Campodavela, 1 - 56122 Pisa | +39 050 7846500

pharmanutragroup.com | pharmanutra.it | info@pharmanutra.it | pharmanutra@pec.it

C.F. / P.Iva / Reg. Impr. 01679440501 - Codice SDI SUBM70N | Cap.Soc. € 1.123.097,70 I.V. | REA 146259

SGS

SGS

FIAT

FARMANOUTTRA

GROUP

PHARMANUTRA

PHARMANUTRA

PHARMANUTRA

AKERN

CERTIFIED

Cetilar

---

emarket

with storage

CERTIFIED

PHARMANUTRA

1. Simonetta Iarlori (*)
2. Pietro Durante (*)

(*) Candidate who has declared that he/she meets the independence requirements set forth in Article 148, paragraph 3, of the TUF and in Article 2, Recommendation 7, of the Corporate Governance Code approved by the Corporate Governance Committee.

It is specified that the documentation accompanying List no. 2 for the appointment of the Board of Directors also includes a declaration by the submitting shareholders attesting to the absence of any relationships of connection and/or significant relationships, including pursuant to Consob Communication no. DEM/9017893 of 26 February 2009, with the shareholders who – on the basis of the disclosures of significant shareholdings pursuant to Article 120 of the TUF or the publication of shareholders’ agreements relevant pursuant to Article 122 of the TUF – hold, also jointly, a controlling interest or a relative majority interest, as provided for by Articles 147-ter, paragraph 3, of the TUF and 144-quinquies of the Issuers’ Regulation adopted by Consob Resolution no. 11971/1999.

It is further announced that the shareholder ALH S.r.l. has filed, within the time limits and in accordance with the procedures set forth by law, the proposed resolutions relating to the appointment of the members of the Board of Directors with reference to items 3.1 and 3.2 on the agenda of the Shareholders’ Meeting, and therefore concerning the number of members of the Board of Directors and the term of office of such members.

The lists, together with the documentation required by the applicable provisions, including those set forth in the Articles of Association, and the proposed resolutions submitted in connection with the appointment of the members of the Board of Directors (items 3.1 and 3.2 on the agenda of the Shareholders’ Meeting), are available at the Company’s registered office, on the Company’s website (www.pharmanutragroup.com, governance/shareholders’ meeting section), and through the authorized storage mechanism eMarket Storage, at .

---

Pharmanutra S.p.A.

Via Campodavela, 1 - 56122 Pisa | +39 050 7846500

pharmanutragroup.com | pharmanutra.it | info@pharmanutra.it | pharmanutra@pec.it

C.F. / P.Iva / Reg. Impr. 01679440501 - Codice SDI SUBM70N | Cap.Soc. € 1.123.097,70 I.V. | REA 146259

SGS

ISO 9001

FARMMONDETRIN

ASSOCIATION

TÜV Rheinland CERTIFIED

ISO 9001

PHARMANUTRA

A K E R N

CERTIFIED

certior

---

emarket

with storage

CERTIFIED

PHARMANUTRA

Pharmanutra S.p.A.

Founded in 2003 in Pisa by Andrea and Roberto Lacorte, Pharmanutra is the holding company of an international Group engaged in the research, development, and commercialization of nutritional supplements, medical devices, and patented raw materials. A leader in iron-based supplements through its Sucrosomial® Technology (SiderAL® and Apportal®), and an emerging player in medical devices for mobility (Cetilar®), the Group internally manages the entire value chain and holds a solid portfolio of patents, brands, and clinical evidence. Pharmanutra operates in over 80 countries, with subsidiaries in the USA and Spain, and also includes Akern S.r.l. (bioimpedance analysis) and Athletica Cetilar S.r.l. (sports medicine).

PharmanutraGroup.com

PharmaNutra.it

For further information:

PharmaNutra S.p.A.
Via Campodavela 1 - 56122 Pisa
Tel. +39 050 7846500
investorrelation@pharmanutra.it
Internal Press Office
press@calabughi.com

Press Office - Spriano Communication & Partners
Via Santa Radegonda, 16 - 20121 Milan
Tel. +39 02 83635708
Matteo Russo
mrusso@sprianocommunication.com
Cristina Tronconi
ctronconi@sprianocommunication.com

Pharmanutra S.p.A.
Via Campodavela, 1 - 56122 Pisa | +39 050 7846500
pharmanutragroup.com | pharmanutra.it | info@pharmanutra.it | pharmanutra@pec.it
C.F. / P.Iva / Reg. Impr. 01679440501 - Codice SDI SUBM70N | Cap.Soc. € 1.123.097,70 I.V. | REA 146259

SGS

SGS

PATONNOLITINA
ASSOCIATIONS
INTERNATIONAL
OF
SCIENCE

PHARMANUTRA
group

PHARMANUTRA
PHARMANUTRA
CERTIFIED

PHARMANUTRA
AKERN
S

---

Fine Comunicato n.20106-15-2026	Numero di Pagine: 5